Literature DB >> 21606087

Burden of atherosclerosis improves the prediction of coronary heart disease but not cerebrovascular events: the Rotterdam Study.

Suzette E Elias-Smale1, Renske G Wieberdink, Arlette E Odink, Albert Hofman, Myriam G M Hunink, Peter J Koudstaal, Gabriel P Krestin, Monique M B Breteler, Aad van der Lugt, Jacqueline C M Witteman.   

Abstract

AIMS: Since atherosclerosis is a systemic process, risk prediction would benefit from targeting multiple components of cardiovascular disease simultaneously. To this end, it is useful to examine the predictive value of non-invasive measures of atherosclerosis in various vascular beds for both coronary heart disease (CHD) and cerebrovascular disease. METHODS AND
RESULTS: Between September 2003 and February 2006, 2153 asymptomatic participants (69.6±6.6 years) from the Rotterdam Study underwent a multi-detector computed tomography scan. During a median follow-up of 3.5 years, 58 CHD events (myocardial infarction and CHD death) and 52 cerebrovascular events (TIA and stroke) occurred. Participants were classified into low (<5%), intermediate (5-10%), and high (>10%) 5-year risk categories based on a refitted Framingham risk model. The model was extended by coronary, aortic arch, or carotid calcium and reclassification percentages were calculated. For the outcome CHD, the C-statistic improved from 0.693 for the Framingham refitted model to 0.743, 0.740, and 0.749 by addition of coronary, aortic arch, and carotid calcium, respectively. Reclassification was most substantial in the intermediate risk group where addition of coronary calcium reclassified 56% of persons [net reclassification improvement (NRI): 15%; P<0.01)]. Adding aortic arch calcium led to a reclassification of 32% of persons (NRI: 8%; P=0.01) and adding carotid calcium reclassified 51% (NRI: 9%; P=0.02). In contrast, calcification in any of the three vascular beds did not improve cerebrovascular risk prediction.
CONCLUSION: Coronary, aortic arch, and carotid artery calcification significantly improved risk prediction of CHD but not of cerebrovascular events.

Entities:  

Mesh:

Year:  2011        PMID: 21606087     DOI: 10.1093/eurheartj/ehr125

Source DB:  PubMed          Journal:  Eur Heart J        ISSN: 0195-668X            Impact factor:   29.983


  16 in total

1.  The Rotterdam Study: 2016 objectives and design update.

Authors:  Albert Hofman; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2015-09-19       Impact factor: 8.082

2.  The Rotterdam Study: 2014 objectives and design update.

Authors:  Albert Hofman; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; M Arfan Ikram; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Ch Stricker; Henning W Tiemeier; André G Uitterlinden; Meike W Vernooij
Journal:  Eur J Epidemiol       Date:  2013-11-21       Impact factor: 8.082

Review 3.  Coronary Artery Calcium: Recommendations for Risk Assessment in Cardiovascular Prevention Guidelines.

Authors:  Mahmoud Al Rifai; Miguel Cainzos-Achirica; Sina Kianoush; Mohammadhassan Mirbolouk; Allison Peng; Josep Comin-Colet; Michael J Blaha
Journal:  Curr Treat Options Cardiovasc Med       Date:  2018-09-26

4.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

5.  Coronary artery calcium and incident cerebrovascular events in an asymptomatic cohort. The MESA Study.

Authors:  Ashleigh O Gibson; Michael J Blaha; Martinson K Arnan; Ralph L Sacco; Moyses Szklo; David M Herrington; Joseph Yeboah
Journal:  JACC Cardiovasc Imaging       Date:  2014-11-10

6.  Association of atherosclerosis in the descending thoracic aorta with coronary artery disease on multi detector row computed tomography coronary angiography in patients with suspected coronary artery disease.

Authors:  Cornelis J Roos; Agnieszka J Witkowska; Michiel A de Graaf; Caroline E Veltman; Victoria Delgado; Greetje J de Grooth; J Wouter Jukema; Jeroen J Bax; Arthur J Scholte
Journal:  Int J Cardiovasc Imaging       Date:  2013-07-27       Impact factor: 2.357

Review 7.  Role of Coronary Calcium Score to Identify Candidates for ASCVD Prevention.

Authors:  Hong Loan Nguyen; Jing Liu; Maygen Del Castillo; Tina Shah
Journal:  Curr Atheroscler Rep       Date:  2019-11-21       Impact factor: 5.113

8.  Noninvasive detection of macrophages in atherosclerotic lesions by computed tomography enhanced with PEGylated gold nanoparticles.

Authors:  Jinbao Qin; Chen Peng; Binghui Zhao; Kaichuang Ye; Fukang Yuan; Zhiyou Peng; Xinrui Yang; Lijia Huang; Mier Jiang; Qinghua Zhao; Guangyu Tang; Xinwu Lu
Journal:  Int J Nanomedicine       Date:  2014-12-02

9.  Brain Arterial Diameters as a Risk Factor for Vascular Events.

Authors:  Jose Gutierrez; Ken Cheung; Ahmet Bagci; Tatjana Rundek; Noam Alperin; Ralph L Sacco; Clinton B Wright; Mitchell S V Elkind
Journal:  J Am Heart Assoc       Date:  2015-08-06       Impact factor: 5.501

10.  Assessment of major adverse cardiovascular events and ischemic stroke with coronary computed tomography angiography based upon angiographic diagnosis in a high-volume single center.

Authors:  Charles K Lin; Ryan J McDonough; Ryan L Prentice; Dustin M Thomas; Kevin E Steel; Bernard J Rubal; Eric A Shry; Todd C Villines; Edward A Hulten; Ahmad M Slim
Journal:  SAGE Open Med       Date:  2014-05-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.